Twisted nanophotonic technology
Preloader Close
x
- Twisted nanophotonic technology for integrated chiroptical sensing of drugs on a chip
At a glance
TwistedNano
Project Focus
Chirality is the asymmetric property of an object that makes it distinguishable from its mirror image
Project Objectives
TwistedNano targets the EU priority area “Health and Safety” by developing a set of new-generation
TwistedNano will be developed by a consortium of 7 European Academic Institutions (UnivAQ – Università degli Studi dell’Aquila, Italy, MPL – Max Planck Institute for The Science of Light, Germany, EPFL – Ecole Polytechnique Fédérale de Lausanne, Switzerland, CNRS – Centre national de la recherche scientifique, France, IIT – Istituto Italiano di Tecnologia, Italy, ICFO – The Institute of Photonic Sciences, Spain and The University of Cyprus ), a global industrial player in pharmaceutics (Dompé Farmaceutici S.p.A., Italy) and a young start-up(Foresee Biosystems, Italy).
TwistedNano aims at developing an innovative platform to measure tiny amounts of chiral drugs.
Publications
Recent scientific articles
Polarization-Shaped Strong Field Control Over Valley Polarization with Mid-IR Light
Tyulnev, J. Poborska, A. Jiménez-Galán, L. Vamos, O. Smirnova, M. Ivanov, J. BiegertProc. 8th Int. Conf. Attosecond Science and Technology, 195-202 (2024).
Attosecond Physics and Quantum Information Science
M. Lewenstein, N. Baldelli, U. Bhattacharya, J. Biegert, M. F. Ciappina, T. Grass, P. T. Grochowski, A. S. Johnson, Th. Lamprou, A. S. Maxwell, A. Ordóñez, E. Pisanty, J. Rivera-Dean, P. Stammer, P. TzallasProc. 8th Int. Conf. Attosecond Science and Technology, 27-63 (2024).
Project details
01/04/2022
48 months
€3.197.925
Andrea Marini (UNIVAQ)